【レポートの概要（一部）】
1. Report Overview
1.1 Rheumatoid Arthritis Overview
1.2 Rheumatoid Arthritis Market Segmentation
1.3 Why You Should Read this Report
1.4 How this Report Delivers
1.5 Main Questions Answered by this Report
1.6 Who is this Report for?
1.7 Research and Analysis Methods
1.8 Frequently Asked Questions (FAQ)
1.9 Some Associated Reports
1.10 About Visiongain
2. What is Rheumatoid Arthritis?
2.1 What Causes Rheumatoid Arthritis?
2.2 How Does the Disease Develop?
2.3 How Can It Be Monitored?
2.4 Can RA Be Cured?
2.5 Performance Criteria Used in Clinical Trials
2.5.1 ACR Criteria For Drug Efficacy
2.5.2 HAQ-DI Measures Daily Activities
2.5.3 mSS Assesses Disease on X-Ray
2.5.4 DAS28 For Disease Severity
2.6 How is RA Treated?
2.6.1 Biologic DMARDs Are the Dominant Source of Revenue
2.6.2 Synthetic DMARDs are the Mainstay of Treatment
2.6.3 Others
2.6.3.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
2.6.3.2 Corticosteroids for Rapid Anti-Inflammatory Effect
2.6.3.3 Analgesics for Rapid Pain Relief
3. World Drug Market for Rheumatoid Arthritis 2016-2026
3.1 The Global Rheumatoid Arthritis Market, 2015
3.2 The Global RA Drugs Market: Revenue Forecast 2015-2026
3.3 The Global RA Drugs Market Segments: Revenue Forecast 2015-2026
3.4 Non-Biologics for RA
3.4.1 NSAIDs: Revenue Forecast, 2015-2026
3.4.2 Synthetic DMARDs: Revenue Forecast, 2015-2026
3.4.3 Others: Revenue Forecast, 2015-2026
3.5 Biologics for RA: Revenue Forecast 2015-2026
4. Leading Drugs in the RA Market 2016-2026
4.1 The Main Drugs in the RA Market, 2015
4.2 Humira: A Major Source of Revenue for AbbVie
4.2.1 Adalimumab Biosimilars
4.2.2 Humira: Revenue Forecast 2015-2026
4.3 Enbrel: Amgen’s Revenue Protected Until 2028
4.3.1 Etanercept Biosimilars
4.3.2 Enbrel: Revenue Forecast 2015-2026
4.4 Remicade: Facing Significant Competition from Biosimilars
4.4.1 Infliximab Biosimilars
4.4.2 Remicade: Revenue Forecast 2015-2026
4.5 Rituxan: Facing Declining Market Share
4.5.1 Rituximab Biosimilars
4.5.2 Rituxan: Revenue Forecast 2015-2026
4.6 Simponi: Market Share Remaining Stable
4.6.1 Simponi: Revenue Forecast 2015-2026
4.7 Orencia: Additional Indications Being Explored
4.7.1 Abatacept Biosimilars
4.7.2 Orencia: Revenue Forecast 2015-2026
4.8 Actemra: First IL-6R Inhibitor Approved for RA
4.8.1 Tocilizumab Biosimilars
4.8.2 Actemra: Revenue Forecast 2015-2026
4.9 Cimzia: Reliable Source of Income for UCB
4.9.1 Certolizumab Biosimilars
4.9.2 Cimzia: Revenue Forecast 2015-2026
4.10 Celebrex: Facing Generic Competition
4.10.1 Celebrex: Revenue Forecast 2015-2026
4.11 Xeljanz: Good Opportunity for Revenue Growth
4.11.1 Xeljanz: Revenue Forecast 2015-2026
4.12 Arcoxia: Sales Revenue Already Declining
4.12.1 Arcoxia: Revenue Forecast 2015-2026
5. Leading National Markets for Rheumatoid Arthritis 2016-2026
5.1 The Leading National Markets in 2015
5.2 The Leading National Markets: Comparison of Revenues and Market Shares to 2026
5.3 The Leading National Markets: Grouped Revenue Forecasts 2016-2026
5.4 The US: Prosperous Economy and Large Patient Population Enables it to Dominate the RA Drugs Market
5.4.1 The US RA Drug Market: Revenue Forecast 2016-2026
5.5 Japan: Remains the Second Largest National Market
5.5.1 The RA Drug Market in Japan: Revenue Forecast 2016-2026
5.6 The EU5 Have 18% Market Share
5.6.1 The RA Drug Market in Germany: Revenue Forecast 2016-2026
5.6.2 The RA Drug Market in France: Revenue Forecast 2016-2026
5.6.3 The RA Drug Market in Italy: Revenue Forecast 2016-2026
5.6.4 The RA Drug Market in Spain: Revenue Forecast 2016-2026
5.6.5 The RA Drug Market in the UK: Revenue Forecast 2016-2026
5.7 China: Expanding Economy with Increasing Market Share
5.7.1 The RA Drug Market in China: Revenue Forecast 2016-2026
5.8 India: Expanding Population Driving Growth
5.8.1 The RA Drug Market in India: Revenue Forecast 2016-2026
5.9 Russia: Expansion Held Back by Troubled Economy
5.9.1 The RA Drug Market in Russia: Revenue Forecast 2016-2026
5.10 Brazil: Focus on Domestic Drug Manufacturing
5.10.1 The RA Drug Market in Brazil: Revenue Forecast 2016-2026
6. Rheumatoid Arthritis R&D Pipeline 2016
6.1 IL-6 Inhibitors Could Rival TNF-Inhibitors
6.1.1 Sarilumab: Already Filed With FDA
6.1.2 Sirukumab: Expected to File in Q3, 2016
6.1.3 Olokizumab: Promising Phase 2 Data
6.1.4 Clazakizumab: Alder Now Collaborating with Vitaeris
6.2 JAK Inhibitors: A Promising Class of Agents
6.2.1 Baricitinib: Potential Competitor to Xeljanz
6.2.2 Peficitinib: Selective JAK-3 Inhibitor From Astellas
6.2.3 ABT-494: Selective JAK-1 Inhibitor From AbbVie
6.2.4 Filgotinib: Following AbbVie’s Withdrawal, Galapagos Now Working with Gilead
6.3 BTK Inhibitors
6.3.1 BMS-986142: Well Tolerated in Phase 1
6.3.2 HM71224: Collaboration with Eli Lilly
6.4 GM-CSF Inhibitor
6.4.1 GSK 3196165: Potential Role in Early Disease
7. Leading Companies in the Rheumatoid Arthritis Drugs Market, 2016
7.1 Introduction to the Leading Companies
7.2 AbbVie: Secured Multiple Patents for Humira
7.3 Roche: Second-Leading Company
7.4 Johnson & Johnson: High Hopes for Sirukumab
7.5 Amgen: Enbrel Sales Protected in the US
7.6 Pfizer: Actively Developing Biosimilars
7.7 Merck & Co.: Remicade Sales in Decline
7.8 BMS: Exploring Additional Indications for Orencia
7.9 UCB: Reliant on Cimzia Revenue
8. Qualitative Analysis of the Rheumatoid Arthritis Drugs Market 2016-2026
8.1 Strengths and Weaknesses of the Rheumatoid Arthritis Market, 2016
8.1.1 Number of Elderly Patients Expected to Rise
8.1.2 Biologics Already Recognised as a Valuable Part of Treatment
8.1.3 Biologics Used in RA Often Have Multiple Indications
8.1.4 Some Patients Have an Inadequate Treatment Response
8.1.5 Efficacy of Drugs Can Diminish Over Time
8.2 Opportunities and Threats Facing the Rheumatoid Arthritis Market, 2016-2026
8.2.1 Need for Effective Drugs With Better Safety Profiles
8.2.2 Need for Less Invasive Routes of Administration
8.2.3 High Number of Products Will Saturate Market
8.2.4 Competition from Biosimilars Will Increase
8.3 Social, Technological, Economic and Political Factors Affecting the Rheumatoid Arthritis Market (STEP Analysis), 2016-2026
8.3.1 Social Factors Influencing the Rheumatoid Arthritis Market
8.3.2 Technological Factors Influencing the Rheumatoid Arthritis Market
8.3.3 Economic Factors Influencing the Rheumatoid Arthritis Market
8.3.4 Political Factors Influencing the Rheumatoid Arthritis Market
8.3.4.1 Government Pressure to Control Costs
8.3.4.2 Inter-country Variability in Biosimilar Approval Process
9. Conclusions
9.1 Global Market for RA Drugs Will Contract After 2018
9.2 Biologics Will Remain the Dominant Drug Class but their Market Share Will Drop By 10%
9.3 Enbrel Will Overtake Humira as the Leading Drug
9.4 US Will Remain the Dominant Market
9.5 Trends in the RA Drugs Market
【レポート販売概要】
■ タイトル：リウマチ性関節炎（RA）治療薬の世界市場2016-2026■ 英文：Rheumatoid Arthritis (RA) Drugs Market 2016-2026
■ 発行日：2016年7月
■ 調査会社：visiongain
■ 商品コード：VGAIN81921
■ 調査対象地域：グローバル
- 北米の計器弁＆取付具市場予測・分析This report focuses on North America Instrumentation Valves and Fittings Market -statistics with detailed classification and splits by market size and growth rate. The North America instrumentation valves and fittings market covers the valves, fittings and pneumatic actuators used in different applications such as semi-conductors, oil & gas, food & beverage, chemical, pharmaceutical, paper & pulp, …
- 甲板機械の世界市場2017-2021About Marine Deck Machinery Market The global marine deck machinery market is dependent on the performance of the global shipbuilding industry. This is because marine deck machineries are essential for water-borne vehicles such as boats, cruises, merchant and passenger ships, tankers, and bulk carriers to move on water. Therefore, a greater demand for building new ships will likely lead to higher …
- 二輪車用無段変速機の世界市場2016-2020About Continuously Variable Transmission Market for Two-Wheelers CVT in two-wheelers is generally used in the scooter segment. Almost all scooters are now equipped with CVT whereas most of the motorbikes are equipped with manual transmission technology. Unlike manual transmission, CVT does not have gear shift but instead has infinite gear ratios, whose transition takes place almost seamlessly with …
- スマートスポーツ用品の世界市場：スマートボール、スマートゴルフスティック、スマートホッケースティック、スマートラケット＆バットSmart sports equipment are those sport equipment that are embedded with sensors that track, monitors, and analyze sport persons or athletes performance. These smart sports equipment also advice sport persons on technique improvements as well as compare their performance with other sport person. These smart sports equipment include smart balls, smart golf sticks, smart helmet, smart rackets, and ot …
- 脳モニタリングの世界市場予測（～2021年）：MRI、CT、PET、EEG、EMG、MEG、TCD、ICP、電極、センサ、ゲル、ケーブルThe global brain monitoring market is expected to reach USD 12.22 Billion by 2021 from USD 8.80 Billion in 2016, growing at a CAGR of 6.8% from 2016 to 2021. The increasing incidence of neurological disorders, rising awareness about neurodegenerative diseases, growth in the number of traumatic brain injuries, and technological advancements are major factors driving the demand for brain monitoring …
- ヨーロッパのIVD（体外診断）市場2016-2020About IVD Market in Europe IVD tests help diagnose, monitor, and assess medical conditions, diseases, and infections in a controlled environment. These tests help in early diagnosis of diseases by enhancing control on test procedures and provide accurate results, leading to quality treatment and shorter hospital stays. They are also minimally invasive and help in lowering treatment costs. Manufact …
- 変色性材料の世界市場機会In this report, n-tech (1) identifies and quantifies the key emerging opportunities for color-shifting materials, (2) offers guidance on where and how these smart materials will be used in the future and (3) profiles the leading firms who are shaping the color-shifting materials space. This report provides full coverage of smart chromic materials with an analysis of the latest technology developme …
- 自動車用トランシーバーの世界市場：プロトコル別（CAN、LIN、Flexray、およびその他）、用途別（安全、車体制御モジュール、シャーシ、パワートレイン、ステアリングホイール、エンジン/気候、ドア/シート、ホイールノード、X-by-wireマスター、その他）、車両タイプ別（乗用車、小型商用車、大型商用車）A transceiver is a device that consists of both receiver as well as transmitter which are combined and also shares common circuitry. There are generally three types of transceivers deployed in automotive applications, which cover CAN transceiver, LIN transceiver, FlexRay transceiver, and others. The global automotive transceivers market is driven by increase in demand for economical and luxury veh …
- 籾殻灰の世界市場予測（～2021）The global rice husk ash market is projected to reach USD 2.54 Billion by 2021, at a CAGR of 5.4% from 2016 to 2021. The increasing use of rice husk ash in place of silica fume and fly ash in the cement and construction industries, and the high demand of RHA in the Asia-Pacific and Middle East & Africa regions are some of the key opportunities for the rice husk ash industry. By application, the bu …
- 水性塗料の世界市場：樹脂別（アクリル、ポリウレタン、エポキシ、アルキド、ポリエステル、PTFE、PVDC、PVDF、その他）、用途別、地域別、セグメント予測The global waterborne coatings market is projected to reach USD 82.9 billion by 2025, according to a new report by Grand View Research, Inc. The market is projected to expand at CAGR of 5.7% over the forecast period. The prices of raw materials used in manufacturing waterborne coatings are expected to have a significant impact on the production cost of the final product. The demand for these raw m …
- 航空宇宙産業におけるナノ技術の世界市場2017-2021About Aerospace Nanotechnology Nanostructure, a part of nanotechnology, is a wide and interdisciplinary area requiring R&D, which gained traction in the last two decades. Nanotechnology is defined as the study and the use of structures smaller than 100 nanometers. This technology is capable of transforming the ways in which materials are produced, and the functionalities of the same can be retaine …
- 坑井仕上げ装置・サービスの世界市場動向・予測（～2021）The well completion equipment & services market is projected to grow at a CAGR of 4.31% from 2016 to 2021 to reach USD 11.09 Billion by 2021. Refracking of mature oil & gas wells and resuming shale operations are the major factors driving the market. The report segments the well completion equipment & services market on the basis of application into onshore and offshore. The offshore application i …
- 世界の遺伝子治療市場展望：腫瘍/感染症/遺伝病/心臓血管疾患/糖尿病/神経疾患治療Gene therapy is the treatment of a disease by replacing, altering, or supplementing a gene that is absent or abnormal and whose absence or abnormality is causing the disease. It has evolved as one of the most sought after research objectives for ‘difficult to cure’ diseases. The gene therapy market, presenting a few marketable products and being nascent in terms of revenue generation, holds tremen …
- 携帯電話ネットワーク基盤M2M通信VAS（付加価値サービス）の世界市場About Cellular-based M2M VAS M2M communication is used for data transmission between electronic devices. In cellular-based M2M connections, CDMA, 2G, 3G, and 4G/LTE networks are used to establish connections between electronic devices. Cellular-based M2M VAS includes managed and professional services, which are offered by MNOs and service providers. Industries such as automotive, healthcare, retai …
- 世界の人材管理市場動向（2012-2016）TechNavio's analysts forecast the Global Human Capital Management market to grow at a CAGR of 10.05 percent over the period 2012-2016. One of the key factors contributing to this market growth is the streamlining of human resource operations. The Global HCM market has also been witnessing the emergence of SaaS-based HCM solutions. However, the fragmentation of the market could pose a challenge to …
